Document is current
Any future updates will be listed below
-
Authors
Moon, Chang Yoon https://orcid.org/0000-0001-8562-6683
Belabed, Meriem https://orcid.org/0000-0002-3210-1581
Park, Matthew D. https://orcid.org/0000-0003-3488-3262
Mattiuz, Raphaël https://orcid.org/0000-0002-3292-1635
Puleston, Daniel https://orcid.org/0000-0002-8437-0732
Merad, Miriam https://orcid.org/0000-0002-4481-7827
- License Information
-
More Information
Article History
Accepted: 12 December 2024
First Online: 7 February 2025
Competing interests
: M.M. serves on the scientific advisory board and/or holds stock from Compugen, Myeloid Therapeutics, Asher Bio, Dren Bio, Oncoresponse, Owkin, OSE, DemBio, Larkspur, Innate Pharma and Genenta; and receives funding for contracted research from Regeneron and Boerhinger Ingelheim. The above interests are not directly relevant to this article. The other authors declare no competing interests.
